Daily update
Monday, 7 June 2021
US regulators approve first new drug since 2003 to treat Alzheimer's
The U.S. Food and Drug Administration (FDA) on Monday approved Aducanumab, which targets the underlying cause of Alzheimer's rather than its symptoms.
from Articles | Mail Online https://ift.tt/3w7fpTe
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment